Neurocrine Biosciences Inc at Piper Sandler Healthcare Conference (Virtual) - Pre-recorded Fireside Chat Transcript
Okay. Good afternoon. This is David Amsellem from the Piper Sandler Specialty Pharma team. And for the next 25 minutes, we're going to be chatting with Neurocrine Biosciences. Lots to talk about. And with us is CFO, Matt Abernethy; and Chief Medical Officer, Eiry Roberts. Thank you both for joining us.
I wanted to turn it over to Matt to make some brief introductory remarks and then we can dive right into Q&A. So Matt, take it away.
Yes. Sounds good, David. Thanks for hosting. And I do apologize upfront. I'm at home. I have a dog at my feet. But Eiry can help cover for me when I -- when my little puppy distracts me too much.
But today is November 18, 2020. I wanted to date stamp that since this is being pre-recorded and we will be making forward-looking statements. So I direct you to our latest SEC filings for the related risk factors, uncertainties associated with our company and then
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
